Aspira Pathlab Diagnostics Ltd vs Park Medi World Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 143.34 as of 29 Sep 10:20 . The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 43.3 on March 2025 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Park Medi World Ltd changed from 31.7 on March 2026 to 31.7 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Aspira Pathlab & Diagnostics Ltd changed from ₹ 31.91 crore on March 2024 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Park Medi World Ltd changed from ₹ 8191 crore on March 2026 to ₹ 8191 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Aspira Pathlab & Diagnostics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Park Medi World Ltd for the Jun '26 is ₹ 483.36 crore as compare to the Mar '26 revenue of ₹ 467.92 crore. This represent the growth of 3.3% The ebitda of Aspira Pathlab & Diagnostics Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Park Medi World Ltd for the Jun '26 is ₹ 133.73 crore as compare to the Mar '26 ebitda of ₹ 134.87 crore. This represent the decline of -0.85% The net profit of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.05 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Park Medi World Ltd changed from ₹ 45.65 crore to ₹ 88.59 crore over 7 quarters. This represents a CAGR of 46.06% The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Park Medi World Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973.
ASDL is a leading pathology specialist, with Pan-India presence.
It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses.
The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers.
Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results.

About Park Medi World Ltd

Park Medi World Quarterly Result Overview Park Medi World quarterly results present a clear summary of financial performance across different reporting periods.
Investors can review revenue, profit, and overall business trends without studying detailed financial statements. Park Medi World quarterly results date helps track when each financial update is released during the year.
The overview shows how the company performs under changing business conditions and the market environment. Key Metrics of Park Medi World Quarterly Result Here are the main metrics typically covered: 1.
Revenue Revenue shows the total income generated from business activities during the reporting period.
Performance changes in quarterly results, such as Park Medi World Q3 results, may reflect seasonal demand and business cycles. 2.

FAQs for the comparison of Aspira Pathlab & Diagnostics Ltd and Park Medi World Ltd

Which company has a larger market capitalization, Aspira Pathlab & Diagnostics Ltd or Park Medi World Ltd?

Market cap of Aspira Pathlab & Diagnostics Ltd is 129 Cr while Market cap of Park Medi World Ltd is 9,308 Cr

What are the key factors driving the stock performance of Aspira Pathlab & Diagnostics Ltd and Park Medi World Ltd?

The stock performance of Aspira Pathlab & Diagnostics Ltd and Park Medi World Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aspira Pathlab & Diagnostics Ltd and Park Medi World Ltd?

As of October 25, 2026, the Aspira Pathlab & Diagnostics Ltd stock price is INR ₹126.05. On the other hand, Park Medi World Ltd stock price is INR ₹215.5.

How do dividend payouts of Aspira Pathlab & Diagnostics Ltd and Park Medi World Ltd compare?

To compare the dividend payouts of Aspira Pathlab & Diagnostics Ltd and Park Medi World Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.